高度なビジュアライゼーション市場 – 2029年までの世界予測

Report Overview

The global Advanced visualization market is projected to reach USD 6.55 billion by 2029 from USD 3.78 billion in 2024, at a CAGR of 11.7% during the forecast period.

世界の高度なビジュアライゼーション市場は、予測期間中のCAGR 11.7%で、2024年の37億8,000万米ドルから2029年までに65億5,000万米ドルに達すると予測されています。

The market is expected to grow as a result of the increasing investments & fundings by public-private organizations, surging demand for technologically advanced visualization solutions for various applications across the industry, such as, cardiology, radiology, neurology, oncology, among others. Moreover, the market has experienced growth due to the need for improved imaging techniques across healthcare industry. However, insufficient IT infrastructure, and reluctance towards adoption of advanced visualization solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.

この市場は、官民組織による投資と資金の増加、特に心臓病学、放射線学、神経学、腫瘍学など、業界全体のさまざまなアプリケーション向けの技術的に高度な視覚化ソリューションに対する需要の急増により、成長すると予想されています。さらに、ヘルスケア業界全体のイメージング技術の向上の必要性により、市場は成長を遂げています。ただし、不十分な IT インフラストラクチャと、新興国における高度な視覚化ソリューションの導入に対する消極的な要因は、市場の成長に課題をもたらすと予想される要因の一部です。

“Cloud-based subsegment, under the advanced visualization software segment is expected to register highest growth during the forecast period.”

The advanced visualization software segment is sub-segmented into on-premise and cloud-based. In 2023, the cloud-based segment is expected to register the highest growth during the forecast period. The growth of the cloud segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, the increasing demand for remote healthcare services and telemedicine solutions has accelerated the adoption of cloud technologies that facilitate easy access to imaging tools and data sharing among healthcare professionals, further contributing to the segment’s growth.

“Hospitals & Ambulatory Surgical Centers is projected to dominate the market in the advanced visualization market, by end user during the forecast period.”

The hospitals & ambulatory surgical centers, diagnostic & imaging centers, academic & research centers, and other end users make up the end user segments of the advanced visualization market. In 2023, the hospitals & ambulatory surgical centers accounted for a significant share of the advanced visualization market, by end user. The segment is also expected to register paramount growth during the forecast period. The prominent position & high growth of this segment is due to the increasing complexity of imaging data, demand for precise diagnostics & surgical planning, rise in minimally-invasive procedures, and the need for interoperability with existing systems. Moreover, the push for personalized medicine and precision therapeutics, the integration of Al and machine learning further strengthens the value of advanced visualization in the provider industry.

“Asia Pacific is expected to register highest market growth during the forecast period.”

The advanced visualization market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register highest growth during the forecast period. The high growth of this region is attributed to the the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across healthcare industry, and significant focus on integrating sophisticated technologies across the workflows also contributes to the growth.

The break-down of primary participants is as mentioned below:

• By Company Type – Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation – Directors: 30%, Manager: 34%, and Others: 36%
• By Region – North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report

o               Agfa-Gevaert Group (Belgium)

o               Canon Medical Systems Corporation (Japan)

o               Fujifilm Holdings Corporation (Japan)

o               GE Healthcare (US)

o               Koninklijke Philips N.V. (Netherlands)

o               Siemens Healthineers AG (Germany)

o               Stryker (US)

o               Change Healthcare (US)

o               TeraRecon  (US)

o               Ziosoft (Japan)

o               Pro Medicus, Ltd (Australia)

o               Carestream Health (US)

o               Fovia, Inc. (US)

o               4DMedical (Australia)

o               Synopsys, Inc. (US)

o               Novarad (US)

o               AnalyzeDirect, Inc. (US)

o               Syntermed Inc. (Netherlands)

o               Pie Medical Imaging B.V. (Netherlands)

o               Infinitt Healthcare Co., Ltd. (US)

o               Biotronics 3D (UK)

o               Minnovaa Innovations Oü (Estonia)

o               Postdicom (Netherlands)

o               CitiusTech Inc (US)

o               Ceevra, Inc. (US)

Research Coverage:

The report analyzes the advanced visualization market and aims to estimate the market size and future growth potential of various market segments, based on offering, solution type, imaging modality, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total advanced visualization market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (booming geriatric population, growing advancements in picture archiving and communication systems and advanced visualization, rising investments by government and private organizations, increasing need for early disease diagnosis), restraints (limited availability of reimbursements, high deployment cost of advanced visualization tools), opportunities (expanding modernization efforts in emerging economies, growing adoption of artificial intelligence and machine learning, increasing establishment of hospitals and diagnostic imaging centers), challenges (shortage of skilled personnel, declining budget allocation for health services) are factors contributing the growth of the advanced visualization market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the advanced visualization market.
• Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the advanced visualization market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global advanced visualization market such as Agfa-Gevaert Group (Belgium), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands).

Table of Contents

1               INTRODUCTION              31

1.1           STUDY OBJECTIVES       31

1.2           MARKET DEFINITION   31

1.3           STUDY SCOPE   32

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      32

1.3.2        INCLUSIONS AND EXCLUSIONS 33

1.3.3        YEARS CONSIDERED      34

1.4           CURRENCY CONSIDERED            34

1.5           STAKEHOLDERS               35

1.6           SUMMARY OF CHANGES               35

2               RESEARCH METHODOLOGY       37

2.1           RESEARCH DATA              37

2.1.1        SECONDARY DATA          38

2.1.1.1    Key data from secondary sources       39

2.1.2        PRIMARY DATA 39

2.1.2.1    Key industry insights           41

2.2           MARKET SIZE ESTIMATION         42

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 47

2.4           MARKET SHARE ESTIMATION    48

2.5           RESEARCH ASSUMPTIONS           48

2.6           RESEARCH LIMITATIONS             48

2.6.1        METHODOLOGY-RELATED LIMITATIONS           48

2.6.2        SCOPE-RELATED LIMITATIONS                 48

2.7           RISK ASSESSMENT           49

3               EXECUTIVE SUMMARY  50

4               PREMIUM INSIGHTS       56

4.1           ADVANCED VISUALIZATION MARKET OVERVIEW                 56

4.2           ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY OFFERING AND COUNTRY           57

4.3           ADVANCED VISUALIZATION MARKET, BY COUNTRY                 58

4.4           ADVANCED VISUALIZATION MARKET: REGIONAL MIX                 58

4.5           ADVANCED VISUALIZATION MARKET: EMERGING ECONOMIES VS.

DEVELOPED MARKETS 59

5               MARKET OVERVIEW       60

5.1           INTRODUCTION              60

5.2           MARKET DYNAMICS       60

5.2.1        DRIVERS               61

5.2.1.1    Booming geriatric population             61

5.2.1.2    Growing advancements in picture archiving and communication systems and advanced visualization   63

5.2.1.3    Rising investments by government and private organizations                 64

5.2.1.4    Increasing need for early disease diagnosis      65

5.2.2        RESTRAINTS      65

5.2.2.1    Limited availability of reimbursements             65

5.2.2.2    High deployment cost of advanced visualization tools   66

5.2.3        OPPORTUNITIES              66

5.2.3.1    Expanding modernization efforts in emerging economies                 66

5.2.3.2    Growing adoption of artificial intelligence and machine learning                 67

5.2.3.3    Increasing establishment of hospitals and diagnostic imaging centers    68

5.2.4        CHALLENGES    68

5.2.4.1    Shortage of skilled personnel              68

5.2.4.2    Declining budget allocation for health services                69

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       69

5.4           PRICING ANALYSIS          70

5.4.1        INDICATIVE SELLING PRICE, BY OFFERING         71

5.4.2        INDICATIVE SELLING PRICE, BY REGION              72

5.5           VALUE CHAIN ANALYSIS               74

5.6           ECOSYSTEM ANALYSIS  75

5.7           INVESTMENT AND FUNDING SCENARIO               77

5.8           TECHNOLOGY ANALYSIS             77

5.8.1        KEY TECHNOLOGIES     77

5.8.1.1    Machine learning and artificial intelligence     77

5.8.1.2    Augmented reality and virtual reality                77

5.8.1.3    Cloud computing  78

5.8.2        COMPLEMENTARY TECHNOLOGIES       78

5.8.2.1    Bioinformatics tools             78

5.8.2.2    Big data analytics 78

5.8.2.3    Internet of things 79

5.8.3        ADJACENT TECHNOLOGIES       79

5.8.3.1    Blockchain             79

5.8.3.2    Quantum computing            79

5.9           INDUSTRY TRENDS         80

5.9.1        INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH DATA-SHARING MODALITIES              80

5.9.2        INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH PICTURE ARCHIVING AND COMMUNICATION SYSTEMS      80

5.10         PATENT ANALYSIS          81

5.11         KEY CONFERENCES AND EVENTS, 2025–2026        83

5.12         CASE STUDY ANALYSIS 85

5.12.1      ENHANCED LEARNING EXPERIENCE USING ADVANCED VISUALIZATION TECHNIQUES  85

5.12.2      IMPROVED DETERMINATION AND SIMULATION OF LYMPH NODE BY 3D RECONSTRUCTION              85

5.12.3      ENHANCED DECISION-MAKING AND TRACKING OF TUMOR PROGRESSION WITH VISUALIZATION TOOLS   86

5.13         REGULATORY LANDSCAPE         86

5.13.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             86

5.13.2      REGULATORY ANALYSIS               89

5.14         PORTER’S FIVE FORCES ANALYSIS           92

5.14.1      THREAT OF NEW ENTRANTS      93

5.14.2      THREAT OF SUBSTITUTES          93

5.14.3      BARGAINING POWER OF SUPPLIERS       93

5.14.4      BARGAINING POWER OF BUYERS             93

5.14.5      INTENSITY OF COMPETITIVE RIVALRY 94

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     94

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           94

5.15.2      BUYING CRITERIA           95

5.16         END-USER ANALYSIS      96

5.16.1      UNMET NEEDS 96

5.16.2      END-USER EXPECTATIONS         98

5.17         ADVANCED VISUALIZATION BUSINESS MODELS                 99

5.17.1      SUBSCRIPTION-BASED MODEL 99

5.17.2      SAAS MODEL     99

5.17.3      ENTERPRISE LICENSING               99

5.17.4      FREEMIUM MODEL         99

5.17.5      CONSULTING SERVICES MODEL               99

5.17.6      PARTNERSHIP/REVENUE-SHARING MODEL        99

5.17.7      HYBRID MODEL                100

5.17.8      SERVICE MODEL               100

5.18         IMPACT OF AI/GENERATIVE AI ON ADVANCED VISUALIZATION MARKET             100

5.18.1      INTRODUCTION              100

5.18.2      MARKET POTENTIAL OF ADVANCED VISUALIZATION                 100

5.18.3      AI USE CASES IN ADVANCED VISUALIZATION    101

5.18.3.1  Key use cases of AI               101

5.18.3.2  Potential use cases of gen AI              102

5.18.4      CASE STUDY      102

5.18.5      IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS              103

5.18.5.1  Diagnostic procedures         103

5.18.5.2  Personalized treatment        104

5.18.5.3  Predictive patient care         104

5.18.5.4  Operational efficiency          104

5.18.5.5  Healthcare imaging              105

5.18.6      USER READINESS AND IMPACT ASSESSMENT     105

5.18.6.1  User readiness       105

5.18.6.1.1                Hospitals & ambulatory surgical centers           105

5.18.6.1.2                Diagnostic & imaging centers             105

5.18.6.1.3                Academic & research centers              106

5.18.6.2  Impact assessment                106

5.18.6.2.1                User A: Hospitals & ambulatory surgical centers                 106

5.18.6.2.1.1            Implementation    106

5.18.6.2.1.2            Impact    107

5.18.6.2.2                User B: Diagnostic & imaging centers               107

5.18.6.2.2.1            Implementation    107

5.18.6.2.2.2            Impact    107

5.18.6.2.3                User C: Academic & research centers                108

5.18.6.2.3.1            Implementation    108

5.18.6.2.3.2            Impact    108

6               ADVANCED VISUALIZATION MARKET, BY OFFERING                 109

6.1           INTRODUCTION              110

6.2           SERVICES             110

6.2.1        IMPLEMENTATION SERVICES    112

6.2.1.1    Rising installation of advanced visualization solutions in hospitals & diagnostic centers to sustain growth              112

6.2.2        CONSULTING/OPTIMIZATION SERVICES              113

6.2.2.1    Increasing adoption of enhanced workflow practices to support growth    113

6.2.3        TRAINING & EDUCATION SERVICES        114

6.2.3.1    Growing adoption of technologically advanced 3D imaging software to drive market      114

6.2.4        POST-SALES & MAINTENANCE SERVICES              115

6.2.4.1    Increasing availability of advanced visualization solutions to propel market        115

6.3           SOFTWARE         116

6.3.1        ON-PREMISE SOFTWARE              118

6.3.1.1    Rising focus on enhanced patient care and operational efficiency to augment growth                118

6.3.2        CLOUD-BASED SOFTWARE         119

6.3.2.1    Increasing demand for remote healthcare services and telemedicine to accelerate growth      119

6.4           HARDWARE        120

6.4.1        GROWING DEMAND FOR HIGH-QUALITY IMAGING IN SPECIALIZED FIELDS TO BOOST MARKET            120

7               ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE     122

7.1           INTRODUCTION              123

7.2           ENTERPRISE-WIDE THIN CLIENT-BASED SOLUTIONS                 123

7.2.1        NEED TO IMPROVE DIAGNOSTIC CAPABILITIES ACROSS HEALTHCARE FACILITIES TO DRIVE MARKET  123

7.3           STANDALONE WORKSTATION-BASED SOLUTIONS                 125

7.3.1        INCREASING COMPLEXITY OF MEDICAL IMAGING DATA TO FACILITATE GROWTH               125

8               ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY         127

8.1           INTRODUCTION              128

8.2           MAGNETIC RESONANCE IMAGING          128

8.2.1        INCREASING INSTALLATIONS OF MAGNETIC RESONANCE IMAGING MACHINES TO SUSTAIN GROWTH                 128

8.3           COMPUTED TOMOGRAPHY        129

8.3.1        RISING NEED FOR PRECISE ASSESSMENT OF COMPLEX ANATOMICAL STRUCTURES TO DRIVE MARKET               129

8.4           POSITRON EMISSION TOMOGRAPHY     131

8.4.1        GROWING ADOPTION OF ADVANCED VISUALIZATION IN ONCOLOGY, NEUROLOGY, AND CARDIOLOGY TO BOOST MARKET               131

8.5           ULTRASOUND  132

8.5.1        GROWING PREFERENCE OF HEALTHCARE PROFESSIONALS FOR ADVANCED ULTRASOUND TO PROPEL MARKET               132

8.6           RADIOTHERAPY               133

8.6.1        RISING DEMAND FOR PERSONALIZED AND PRECISE CANCER TREATMENT TO PROMOTE GROWTH 133

8.7           NUCLEAR MEDICINE     134

8.7.1        NEED TO ASSESS HEALTH AND FUNCTIONING OF CRITICAL ORGANS TO SUPPORT GROWTH         134

8.8           OTHER IMAGING MODALITIES 135

9               ADVANCED VISUALIZATION MARKET, BY APPLICATION                 137

9.1           INTRODUCTION              138

9.2           RADIOLOGICAL/INTERVENTIONAL RADIOLOGICAL APPLICATIONS 138

9.2.1        ONGOING TREND OF PROCESS AUTOMATION AND WORKFLOW DIGITIZATION TO AUGMENT GROWTH     138

9.3           CARDIOLOGICAL APPLICATIONS             140

9.3.1        GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET         140

9.4           ORTHOPEDIC APPLICATIONS   141

9.4.1        INCREASING ADVANCEMENTS IN HOLOGRAPHIC TECHNOLOGY AND VIRTUAL REALITY TO EXPEDITE GROWTH                 141

9.5           ONCOLOGICAL APPLICATIONS 142

9.5.1        RISING INCIDENCE OF CANCER TO CONTRIBUTE TO SEGMENT GROWTH       142

9.6           VASCULAR APPLICATIONS          143

9.6.1        NEED FOR PRECISE IMAGING TO SUSTAIN GROWTH                 143

9.7           NEUROLOGICAL APPLICATIONS              144

9.7.1        GROWING ADVANCEMENTS IN NEUROIMAGING TECHNIQUES TO FUEL MARKET               144

9.8           OTHER APPLICATIONS 146

10            ADVANCED VISUALIZATION MARKET, BY END USER                 147

10.1         INTRODUCTION              148

10.2         HOSPITALS & AMBULATORY SURGICAL CENTERS                 148

10.2.1      HIGH ADOPTION RATE OF DIAGNOSTIC PROCEDURES FOR EARLY DISEASE DETECTION TO CONTRIBUTE TO GROWTH             148

10.3         DIAGNOSTIC & IMAGING CENTERS         149

10.3.1      INCREASING PREVALENCE OF CHRONIC DISEASES TO FAVOR GROWTH              149

10.4         ACADEMIC & RESEARCH CENTERS           151

10.4.1      GROWING NUMBER OF FUNDS AND GRANTS FOR RESEARCH ACTIVITIES TO DRIVE MARKET          151

10.5         OTHER END USERS         152

11            ADVANCED VISUALIZATION MARKET, BY REGION                 153

11.1         INTRODUCTION              154

11.2         NORTH AMERICA             154

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 155

11.2.2      US           160

11.2.2.1  Continuous technological advancements in diagnostic imaging modalities to promote growth             160

11.2.3      CANADA               163

11.2.3.1  Increasing prevalence of heart ailments to expedite growth                 163

11.3         EUROPE               166

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      166

11.3.2      GERMANY           170

11.3.2.1  Rapid growth of diagnostic imaging research activities and outsourcing of testing to boost market              170

11.3.3      UK          174

11.3.3.1  Rising acceptance of advanced diagnostic imaging techniques to aid growth              174

11.3.4      FRANCE                176

11.3.4.1  Easy accessibility to diagnostic assay procedures and availability of low-cost surgical facilities to spur growth    176

11.3.5      SPAIN    180

11.3.5.1  Increasing access to advanced cancer screening programs to stimulate growth   180

11.3.6      ITALY    183

11.3.6.1  Growing adoption of digitized diagnostic techniques to fuel market    183

11.3.7      REST OF EUROPE             186

11.4         ASIA PACIFIC     190

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 190

11.4.2      JAPAN   195

11.4.2.1  Favorable reimbursement system and growing access to healthcare systems to propel market 195

11.4.3      CHINA  199

11.4.3.1  Changing lifestyle and growing purchasing power to accelerate growth    199

11.4.4      INDIA    202

11.4.4.1  Rising trend of medical tourism to augment growth       202

11.4.5      REST OF ASIA PACIFIC   205

11.5         LATIN AMERICA                208

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 208

11.5.2      BRAZIL 212

11.5.2.1  Free and universal public health system to contribute to market growth    212

11.5.3      MEXICO                214

11.5.3.1  Growing adoption of advanced devices to fuel market   214

11.5.4      REST OF LATIN AMERICA             217

11.6         MIDDLE EAST & AFRICA                221

11.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 221

11.6.2      GCC COUNTRIES              225

11.6.2.1  Growing focus on improving healthcare services and infrastructure to drive market             225

11.6.3      REST OF MIDDLE EAST & AFRICA             228

12            COMPETITIVE LANDSCAPE         232

12.1         OVERVIEW          232

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021–DECEMBER 2024     232

12.3         REVENUE ANALYSIS, 2019–2023  237

12.4         MARKET SHARE ANALYSIS, 2023                 238

12.5         COMPANY VALUATION AND FINANCIAL METRICS                 240

12.6         BRAND/PRODUCT COMPARISON             242

12.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 243

12.7.1      STARS   243

12.7.2      EMERGING LEADERS     243

12.7.3      PERVASIVE PLAYERS      243

12.7.4      PARTICIPANTS 243

12.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         245

12.7.5.1  Company footprint               245

12.7.5.2  Application footprint            246

12.7.5.3  Solution type footprint         247

12.7.5.4  Imaging modality footprint 248

12.7.5.5  Component footprint           249

12.7.5.6  End-user footprint                250

12.7.5.7  Region footprint   251

12.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        252

12.8.1      PROGRESSIVE COMPANIES         252

12.8.2      RESPONSIVE COMPANIES            252

12.8.3      DYNAMIC COMPANIES  252

12.8.4      STARTING BLOCKS         252

12.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 254

12.8.5.1  Detailed list of key startups/SMEs    254

12.8.5.2  Competitive benchmarking of key startups/SMEs          255

12.9         COMPETITIVE SCENARIO             257

12.9.1      PRODUCT LAUNCHES AND UPGRADES 257

12.9.2      DEALS  259

13            COMPANY PROFILES      261

13.1         KEY PLAYERS     261

13.1.1      AGFA-GEVAERT GROUP                261

13.1.1.1  Business overview 261

13.1.1.2  Products/Solutions/Services offered 262

13.1.1.3  Recent developments           263

13.1.1.3.1                Deals      263

13.1.1.4  MnM view              265

13.1.1.4.1                Right to win           265

13.1.1.4.2                Strategic choices   265

13.1.1.4.3                Weaknesses and competitive threats 265

13.1.2      CANON MEDICAL SYSTEMS CORPORATION        266

13.1.2.1  Business overview 266

13.1.2.2  Products/Solutions/Services offered 267

13.1.2.3  Recent developments           268

13.1.2.3.1                Deals      268

13.1.2.4  MnM view              269

13.1.2.4.1                Right to win           269

13.1.2.4.2                Strategic choices   269

13.1.2.4.3                Weaknesses and competitive threats 269

13.1.3      FUJIFILM HOLDINGS CORPORATION     270

13.1.3.1  Business overview 270

13.1.3.2  Products/Solutions/Services offered 271

13.1.3.3  Recent developments           273

13.1.3.3.1                Product launches and upgrades         273

13.1.3.3.2                Deals      273

13.1.4      GE HEALTHCARE             274

13.1.4.1  Business overview 274

13.1.4.2  Products/Solutions/Services offered 275

13.1.4.3  Recent developments           276

13.1.4.3.1                Product launches and upgrades         276

13.1.4.3.2                Deals      277

13.1.4.4  MnM view              277

13.1.4.4.1                Right to win           277

13.1.4.4.2                Strategic choices   277

13.1.4.4.3                Weaknesses and competitive threats 277

13.1.5      SIEMENS HEALTHINEERS AG      278

13.1.5.1  Business overview 278

13.1.5.2  Products/Solutions/Services offered 279

13.1.5.3  MnM view              280

13.1.5.3.1                Right to win           280

13.1.5.3.2                Strategic choices   280

13.1.5.3.3                Weaknesses and competitive threats 280

13.1.6      KONINKLIJKE PHILIPS N.V.          281

13.1.6.1  Business overview 281

13.1.6.2  Products/Solutions/Services offered 282

13.1.6.3  Recent developments           283

13.1.6.3.1                Product launches and upgrades         283

13.1.6.3.2                Deals      284

13.1.6.4  MnM view              285

13.1.6.4.1                Right to win           285

13.1.6.4.2                Strategic choices   285

13.1.6.4.3                Weaknesses and competitive threats 285

13.1.7      STRYKER              286

13.1.7.1  Business overview 286

13.1.7.2  Products/Solutions/Services offered 287

13.1.7.3  Recent developments           288

13.1.7.3.1                Product launches and upgrades         288

13.1.7.3.2                Deals      288

13.1.8      CHANGE HEALTHCARE (UNITEDHEALTH GROUP)                 289

13.1.8.1  Business overview 289

13.1.8.2  Products/Solutions/Services offered 290

13.1.8.3  Recent developments           291

13.1.8.3.1                Deals      291

13.1.9      TERARECON      292

13.1.9.1  Business overview 292

13.1.9.2  Products/Solutions/Services offered 292

13.1.9.3  Recent developments           293

13.1.9.3.1                Product launches and upgrades         293

13.1.9.3.2                Deals      293

13.1.10   ZIOSOFT              295

13.1.10.1                 Business overview 295

13.1.10.2                 Products/Solutions/Services offered 295

13.1.10.3                 Recent developments           296

13.1.10.3.1             Product launches and upgrades         296

13.1.11   PRO MEDICUS, LTD.       297

13.1.11.1                 Business overview 297

13.1.11.2                 Products/Solutions/Services offered 298

13.1.11.3                 Recent developments           298

13.1.11.3.1             Other Developments            298

13.1.12   CARESTREAM HEALTH  300

13.1.12.1                 Business overview 300

13.1.12.2                 Products/Solutions/Services offered 300

13.1.12.3                 Recent developments           301

13.1.12.3.1             Product launches and upgrades         301

13.1.13   FOVIA, INC.         302

13.1.13.1                 Business overview 302

13.1.13.2                 Products/Solutions/Services offered 302

13.1.13.3                 Recent developments           303

13.1.13.3.1             Deals      303

13.1.14   4DMEDICAL       304

13.1.14.1                 Business overview 304

13.1.14.2                 Products/Solutions/Services offered 305

13.1.14.3                 Recent developments           305

13.1.14.3.1             Deals      305

13.1.15   SYNOPSYS, INC. 306

13.1.15.1                 Business overview 306

13.1.15.2                 Products/Solutions/Services offered 307

13.1.15.3                 Recent developments           308

13.1.15.3.1             Deals      308

13.1.16   NOVARAD           309

13.1.16.1                 Business overview 309

13.1.16.2                 Products/Solutions/Services offered 309

13.1.17   ANALYZEDIRECT, INC.  311

13.1.17.1                 Business overview 311

13.1.17.2                 Products/Solutions/Services offered 311

13.1.18   SYNTERMED INC.             312

13.1.18.1                 Business overview 312

13.1.18.2                 Products/Solutions/Services offered 312

13.1.19   PIE MEDICAL IMAGING B.V.        313

13.1.19.1                 Business overview 313

13.1.19.2                 Products/Solutions/Services offered 313

13.1.19.3                 Recent developments           314

13.1.19.3.1             Product launches and upgrades         314

13.1.19.3.2             Deals      314

13.1.20   INFINITT HEALTHCARE CO., LTD.            315

13.1.20.1                 Business overview 315

13.1.20.2                 Products/Solutions/Services offered 315

13.1.20.3                 Recent developments           316

13.1.20.3.1             Deals      316

13.2         OTHER PLAYERS              317

13.2.1      BIOTRONICS 3D                317

13.2.2      MINNOVAA INNOVATIONS OÜ  318

13.2.3      POSTDICOM      319

13.2.4      CITIUSTECH INC.             320

13.2.5      CEEVRA, INC.     321

14            APPENDIX           322

14.1         DISCUSSION GUIDE        322

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                327

14.3         CUSTOMIZATION OPTIONS        329

14.4         RELATED REPORTS         329

14.5         AUTHOR DETAILS           330

LIST OF TABLES

TABLE 1                ADVANCED VISUALIZATION MARKET: INCLUSIONS AND EXCLUSIONS 33

TABLE 2                EXCHANGE RATES FOR USD CONVERSION                 34

TABLE 3                ADVANCED VISUALIZATION MARKET: RISK ASSESSMENT     49

TABLE 4                ADVANCED VISUALIZATION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS           61

TABLE 5                AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES          62

TABLE 6                INDICATIVE SELLING PRICE OF ADVANCED VISUALIZATION SOLUTIONS,

BY OFFERING, 2021–2023 (USD) 71

TABLE 7                INDICATIVE SELLING PRICE OF ADVANCED VISUALIZATION SOLUTIONS, BY REGION, 2021–2023 (USD)                 72

TABLE 8                ADVANCED VISUALIZATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM       76

TABLE 9                TOP APPLICANTS FOR PATENTS RELATED TO ADVANCED VISUALIZATION, JANUARY 2011–JANUARY 2025                 81

TABLE 10              ADVANCED VISUALIZATION MARKET: INNOVATIONS AND

PATENT REGISTRATIONS, 2021  82

TABLE 11              ADVANCED VISUALIZATION MARKET: KEY CONFERENCES AND EVENTS,

2025–2026              83

TABLE 12              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 86

TABLE 13              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           87

TABLE 14              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 87

TABLE 15              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 88

TABLE 16              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 89

TABLE 17              REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN NORTH AMERICA  89

TABLE 18              REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN EUROPE    90

TABLE 19              REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN ASIA PACIFIC           90

TABLE 20              REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN MIDDLE EAST & AFRICA     91

TABLE 21              REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN LATIN AMERICA    91

TABLE 22              ADVANCED VISUALIZATION MARKET: PORTER’S FIVE FORCES 93

TABLE 23              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)    95

TABLE 24              KEY BUYING CRITERIA FOR END USERS                 96

TABLE 25              UNMET NEEDS IN ADVANCED VISUALIZATION MARKET               97

TABLE 26              END-USER EXPECTATIONS IN ADVANCED VISUALIZATION MARKET             98

TABLE 27              ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022–2029 (USD MILLION)     110

TABLE 28             ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            111

TABLE 29             ADVANCED VISUALIZATION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            111

TABLE 30              ADVANCED VISUALIZATION MARKET FOR IMPLEMENTATION SERVICES, BY REGION, 2022–2029 (USD MILLION)            112

TABLE 31              ADVANCED VISUALIZATION MARKET FOR CONSULTING/OPTIMIZATION SERVICES, BY REGION, 2022–2029 (USD MILLION) 114

TABLE 32              ADVANCED VISUALIZATION MARKET FOR TRAINING & EDUCATION SERVICES,

BY REGION, 2022–2029 (USD MILLION)   115

TABLE 33              ADVANCED VISUALIZATION MARKET FOR POST-SALES & MAINTENANCE SERVICES, BY REGION, 2022–2029 (USD MILLION) 116

TABLE 34              ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT,

2022–2029 (USD MILLION)            117

TABLE 35              ADVANCED VISUALIZATION SOFTWARE MARKET, BY REGION,

2022–2029 (USD MILLION)            117

TABLE 36              ADVANCED VISUALIZATION MARKET FOR ON-PREMISE SOFTWARE, BY REGION, 2022–2029 (USD MILLION)                 118

TABLE 37              ADVANCED VISUALIZATION MARKET FOR CLOUD-BASED SOFTWARE, BY REGION, 2022–2029 (USD MILLION)            120

TABLE 38              ADVANCED VISUALIZATION HARDWARE MARKET, BY REGION,

2022–2029 (USD MILLION)            121

TABLE 39              ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            123

TABLE 40              ADVANCED VISUALIZATION MARKET FOR ENTERPRISE-WIDE THIN CLIENT-BASED SOLUTIONS, BY REGION, 2022–2029 (USD MILLION)          124

TABLE 41              ADVANCED VISUALIZATION MARKET FOR STANDALONE WORKSTATION-BASED SOLUTIONS, BY REGION, 2022–2029 (USD MILLION)            126

TABLE 42              ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            128

TABLE 43              ADVANCED VISUALIZATION MARKET FOR MAGNETIC RESONANCE IMAGING,

BY REGION, 2022–2029 (USD MILLION)   129

TABLE 44              ADVANCED VISUALIZATION MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2022–2029 (USD MILLION)            130

TABLE 45              ADVANCED VISUALIZATION MARKET FOR POSITRON EMISSION TOMOGRAPHY,

BY REGION, 2022–2029 (USD MILLION)   131

TABLE 46              ADVANCED VISUALIZATION MARKET FOR ULTRASOUND, BY REGION,

2022–2029 (USD MILLION)            133

TABLE 47              ADVANCED VISUALIZATION MARKET FOR RADIOTHERAPY, BY REGION,

2022–2029 (USD MILLION)            134

TABLE 48              ADVANCED VISUALIZATION MARKET FOR NUCLEAR MEDICINE, BY REGION,

2022–2029 (USD MILLION)            135

TABLE 49              ADVANCED VISUALIZATION MARKET FOR OTHER IMAGING MODALITIES,

BY REGION, 2022–2029 (USD MILLION)   136

TABLE 50              ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              138

TABLE 51              ADVANCED VISUALIZATION MARKET FOR RADIOLOGICAL/INTERVENTIONAL RADIOLOGICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)  139

TABLE 52              ADVANCED VISUALIZATION MARKET FOR CARDIOLOGICAL APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   141

TABLE 53              ADVANCED VISUALIZATION MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            142

TABLE 54              ADVANCED VISUALIZATION MARKET FOR ONCOLOGICAL APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   143

TABLE 55              ADVANCED VISUALIZATION MARKET FOR VASCULAR APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            144

TABLE 56              ADVANCED VISUALIZATION MARKET FOR NEUROLOGICAL APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   145

TABLE 57              ADVANCED VISUALIZATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)                 146

TABLE 58              ADVANCED VISUALIZATION MARKET, BY END USER, 2022–2029 (USD MILLION)                148

TABLE 59              ADVANCED VISUALIZATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2022–2029 (USD MILLION)            149

TABLE 60              ADVANCED VISUALIZATION MARKET FOR DIAGNOSTIC & IMAGING CENTERS,

BY REGION, 2022–2029 (USD MILLION)   150

TABLE 61              ADVANCED VISUALIZATION MARKET FOR ACADEMIC & RESEARCH CENTERS,

BY REGION, 2022–2029 (USD MILLION)   151

TABLE 62              ADVANCED VISUALIZATION MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)            152

TABLE 63              ADVANCED VISUALIZATION MARKET, BY REGION, 2022–2029 (USD MILLION)          154

TABLE 64              NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            155

TABLE 65              NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            155

TABLE 66              NORTH AMERICA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          156

TABLE 67              NORTH AMERICA: ADVANCED VISUALIZATION SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2029 (USD MILLION)      156

TABLE 68              NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            156

TABLE 69              NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022–2029 (USD MILLION)                 157

TABLE 70              NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            157

TABLE 71              NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            158

TABLE 72              US: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            160

TABLE 73              US: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            161

TABLE 74              US: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT,

2022–2029 (USD MILLION)            161

TABLE 75              US: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            161

TABLE 76              US: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            162

TABLE 77              US: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            162

TABLE 78              US: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            163

TABLE 79             CANADA: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            163

TABLE 80              CANADA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            164

TABLE 81              CANADA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022–2029 (USD MILLION)            164

TABLE 82             CANADA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            164

TABLE 83             CANADA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)          165

TABLE 84             CANADA: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            165

TABLE 85             CANADA: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            166

TABLE 86              EUROPE: ADVANCED VISUALIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            167

TABLE 87              EUROPE: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            167

TABLE 88              EUROPE: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            168

TABLE 89              EUROPE: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022–2029 (USD MILLION)            168

TABLE 90              EUROPE: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            168

TABLE 91              EUROPE: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            169

TABLE 92              EUROPE: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            169

TABLE 93              EUROPE: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            170

TABLE 94              GERMANY: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            171

TABLE 95              GERMANY: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            171

TABLE 96              GERMANY: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022–2029 (USD MILLION)            171

TABLE 97              GERMANY: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            172

TABLE 98              GERMANY: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            172

TABLE 99              GERMANY: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            173

TABLE 100            GERMANY: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            173

TABLE 101            UK: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            174

TABLE 102            UK: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            174

TABLE 103            UK: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT,

2022–2029 (USD MILLION)            175

TABLE 104            UK: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            175

TABLE 105            UK: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            175

TABLE 106            UK: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            176

TABLE 107            UK: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            176

TABLE 108            FRANCE: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            177

TABLE 109            FRANCE: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            177

TABLE 110            FRANCE: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022–2029 (USD MILLION)            178

TABLE 111            FRANCE: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            178

TABLE 112            FRANCE: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            178

TABLE 113            FRANCE: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            179

TABLE 114            FRANCE: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            179

TABLE 115            SPAIN: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            180

TABLE 116            SPAIN: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2

022–2029 (USD MILLION)               181

TABLE 117            SPAIN: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT,

2022–2029 (USD MILLION)            181

TABLE 118            SPAIN: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            181

TABLE 119            SPAIN: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            182

TABLE 120            SPAIN: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            182

TABLE 121            SPAIN: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            183

TABLE 122            ITALY: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            184

TABLE 123            ITALY: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            184

TABLE 124            ITALY: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT,

2022–2029 (USD MILLION)            184

TABLE 125            ITALY: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            185

TABLE 126            ITALY: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            185

TABLE 127            ITALY: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            186

TABLE 128            ITALY: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            186

TABLE 129            REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            187

TABLE 130            REST OF EUROPE: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            187

TABLE 131            REST OF EUROPE: ADVANCED VISUALIZATION SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2029 (USD MILLION)      187

TABLE 132            REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            188

TABLE 133            REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022–2029 (USD MILLION)                 188

TABLE 134            REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            189

TABLE 135            REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            189

TABLE 136            ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            191

TABLE 137            ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            191

TABLE 138            ASIA PACIFIC: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            191

TABLE 139            ASIA PACIFIC: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022–2029 (USD MILLION)            192

TABLE 140            ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            192

TABLE 141            ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            193

TABLE 142            ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            193

TABLE 143            ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            194

TABLE 144            JAPAN: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            196

TABLE 145            JAPAN: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            196

TABLE 146            JAPAN: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT,

2022–2029 (USD MILLION)            197

TABLE 147            JAPAN: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            197

TABLE 148            JAPAN: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            197

TABLE 149            JAPAN: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            198

TABLE 150            JAPAN: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            198

TABLE 151            CHINA: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            199

TABLE 152            CHINA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            200

TABLE 153            CHINA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT,

2022–2029 (USD MILLION)            200

TABLE 154            CHINA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            200

TABLE 155            CHINA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            201

TABLE 156            CHINA: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            201

TABLE 157            CHINA: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            202

TABLE 158            INDIA: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            202

TABLE 159            INDIA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            203

TABLE 160            INDIA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT,

2022–2029 (USD MILLION)            203

TABLE 161            INDIA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            203

TABLE 162            INDIA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            204

TABLE 163            INDIA: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            204

TABLE 164            INDIA: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            205

TABLE 165            REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            205

TABLE 166            REST OF ASIA PACIFIC: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            206

TABLE 167            REST OF ASIA PACIFIC: ADVANCED VISUALIZATION SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2029 (USD MILLION)      206

TABLE 168            REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022–2029 (USD MILLION)            206

TABLE 169            REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022–2029 (USD MILLION) 207

TABLE 170            REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            207

TABLE 171            REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            208

TABLE 172            LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            209

TABLE 173            LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            209

TABLE 174            LATIN AMERICA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            209

TABLE 175            LATIN AMERICA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022–2029 (USD MILLION)            210

TABLE 176            LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            210

TABLE 177            LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022–2029 (USD MILLION)                 210

TABLE 178            LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            211

TABLE 179            LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            211

TABLE 180            BRAZIL: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            212

TABLE 181            BRAZIL: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            212

TABLE 182            BRAZIL: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT,

2022–2029 (USD MILLION)            213

TABLE 183            BRAZIL: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            213

TABLE 184            BRAZIL: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            213

TABLE 185            BRAZIL: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            214

TABLE 186            BRAZIL: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            214

TABLE 187            MEXICO: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            215

TABLE 188            MEXICO: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            215

TABLE 189            MEXICO: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022–2029 (USD MILLION)            215

TABLE 190            MEXICO: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            216

TABLE 191            MEXICO: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2022–2029 (USD MILLION)            216

TABLE 192            MEXICO: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            217

TABLE 193            MEXICO: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            217

TABLE 194            REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022–2029 (USD MILLION)            218

TABLE 195            REST OF LATIN AMERICA: ADVANCED VISUALIZATION SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         218

TABLE 196            REST OF LATIN AMERICA: ADVANCED VISUALIZATION SOFTWARE MARKET,

BY DEPLOYMENT, 2022–2029 (USD MILLION)      219

TABLE 197            REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022–2029 (USD MILLION)            219

TABLE 198            REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022–2029 (USD MILLION) 220

TABLE 199            REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            220

TABLE 200            REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022–2029 (USD MILLION)            221

TABLE 201            MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY REGION,

2022–2029 (USD MILLION)            222

TABLE 202            MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022–2029 (USD MILLION)            222

TABLE 203            MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            223

TABLE 204            MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)            223

TABLE 205            MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022–2029 (USD MILLION)            223

TABLE 206            MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022–2029 (USD MILLION) 224

TABLE 207            MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            224

TABLE 208            MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022–2029 (USD MILLION)            225

TABLE 209            GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            225

TABLE 210            GCC COUNTRIES: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            226

TABLE 211            GCC COUNTRIES: ADVANCED VISUALIZATION SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)            226

TABLE 212            GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2022–2029 (USD MILLION)            226

TABLE 213            GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022–2029 (USD MILLION)                 227

TABLE 214            GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            227

TABLE 215            GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)            228

TABLE 216            REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               228

TABLE 217            REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)            229

TABLE 218            REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)            229

TABLE 219            REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET,

BY SOLUTION TYPE, 2022–2029 (USD MILLION) 229

TABLE 220            REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET,

BY IMAGING MODALITY, 2022–2029 (USD MILLION)         230

TABLE 221            REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       230

TABLE 222            REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET,

BY END USER, 2022–2029 (USD MILLION)               231

TABLE 223            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ADVANCED VISUALIZATION MARKET, JANUARY 2021–DECEMBER 2024     233

TABLE 224            ADVANCED VISUALIZATION MARKET: DEGREE OF COMPETITION           239

TABLE 225            ADVANCED VISUALIZATION MARKET: APPLICATION FOOTPRINT         246

TABLE 226            ADVANCED VISUALIZATION MARKET: SOLUTION TYPE              247

TABLE 227            ADVANCED VISUALIZATION MARKET: IMAGING MODALITY FOOTPRINT           248

TABLE 228            ADVANCED VISUALIZATION MARKET: COMPONENT FOOTPRINT          249

TABLE 229            ADVANCED VISUALIZATION MARKET: END-USER FOOTPRINT            250

TABLE 230            ADVANCED VISUALIZATION MARKET: REGION FOOTPRINT       251

TABLE 231            ADVANCED VISUALIZATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES             254

TABLE 232            ADVANCED VISUALIZATION MARKET: COMPETITIVE BENCHMARKING OF

KEY STARTUPS/SMES, BY KEY PLAYER   255

TABLE 233            ADVANCED VISUALIZATION MARKET: COMPETITIVE BENCHMARKING OF

KEY STARTUPS/SMES, BY END USER & REGION 256

TABLE 234            ADVANCED VISUALIZATION MARKET: COMPETITIVE BENCHMARKING OF

KEY STARTUPS/SMES, BY IMAGING MODALITY 257

TABLE 235            ADVANCED VISUALIZATION MARKET: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021–DECEMBER 2024                258

TABLE 236            ADVANCED VISUALIZATION MARKET: DEALS, JANUARY 2021–DECEMBER 2024 259

TABLE 237            AGFA-GEVAERT GROUP: COMPANY OVERVIEW                 261

TABLE 238            AGFA-GEVAERT GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED    262

TABLE 239            AGFA-GEVAERT GROUP: DEALS, JANUARY 2021–DECEMBER 2024                263

TABLE 240            CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW   266

TABLE 241            CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED    267

TABLE 242            CANON MEDICAL SYSTEMS CORPORATION: DEALS,

JANUARY 2021–DECEMBER 2024 268

TABLE 243            FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW   270

TABLE 244            FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED    271

TABLE 245            FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021–DECEMBER 2024                273

TABLE 246            FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021– SEPTEMBER 2024               273

TABLE 247            GE HEALTHCARE: COMPANY OVERVIEW                 274

TABLE 248            GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED    275

TABLE 249            GE HEALTHCARE: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021–DECEMBER 2024        276

TABLE 250            GE HEALTHCARE: DEALS, JANUARY 2021– JULY 2024        277

TABLE 251            SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW          278

TABLE 252            SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED    279

TABLE 253            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          281

TABLE 254            KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    282

TABLE 255            KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021–DECEMBER 2024                 283

TABLE 256            KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–DECEMBER 2024     284

TABLE 257            STRYKER: COMPANY OVERVIEW               286

TABLE 258            STRYKER: PRODUCTS/SOLUTIONS/SERVICES OFFERED             287

TABLE 259            STRYKER: PRODUCT LAUNCHES AND UPGRADES,

JANUARY 2021–DECEMBER 2024 288

TABLE 260            STRYKER: DEALS, JANUARY 2021– SEPTEMBER 2024        288

TABLE 261            CHANGE HEALTHCARE (UNITEDHEALTH GROUP): COMPANY OVERVIEW                289

TABLE 262            CHANGE HEALTHCARE (UNITEDHEALTH GROUP): PRODUCTS/SOLUTIONS/SERVICES OFFERED 290

TABLE 263            CHANGE HEALTHCARE (UNITEDHEALTH GROUP): DEALS, JANUARY 2021– DECEMBER 2024             291

TABLE 264            TERARECON: COMPANY OVERVIEW       292

TABLE 265            TERARECON: PRODUCTS/SOLUTIONS/SERVICES OFFERED    292

TABLE 266            TERARECON: PRODUCT LAUNCHES AND UPGRADES,

JANUARY 2021–DECEMBER 2024 293

TABLE 267            TERARECON: DEALS, JANUARY 2021–DECEMBER 2024        293

TABLE 268            ZIOSOFT: COMPANY OVERVIEW               295

TABLE 269            ZIOSOFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED             295

TABLE 270            ZIOSOFT: PRODUCT LAUNCHES AND UPGRADES,

JANUARY 2021–DECEMBER 2024 296

TABLE 271            PRO MEDICUS, LTD.: COMPANY OVERVIEW                 297

TABLE 272            PRO MEDICUS, LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    298

TABLE 273            PRO MEDICUS, LTD.: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024 298

TABLE 274            CARESTREAM HEALTH: COMPANY OVERVIEW                 300

TABLE 275            CARESTREAM HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED    300

TABLE 276            CARESTREAM HEALTH: PRODUCT LAUNCHES AND UPGRADES,

JANUARY 2021–DECEMBER 2024 301

TABLE 277            FOVIA, INC.: COMPANY OVERVIEW         302

TABLE 278            FOVIA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED             302

TABLE 279            FOVIA, INC.: DEALS, JANUARY 2021– DECEMBER 2024        303

TABLE 280            4DMEDICAL: COMPANY OVERVIEW        304

TABLE 281            4DMEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED    305

TABLE 282            4DMEDICAL: DEALS, JANUARY 2021– SEPTEMBER 2024              305

TABLE 283            SYNOPSYS, INC.: COMPANY OVERVIEW 306

TABLE 284            SYNOPSYS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    307

TABLE 285            SYNOPSYS, INC.: DEALS, JANUARY 2021–DECEMBER 2024                308

TABLE 286            NOVARAD: COMPANY OVERVIEW            309

TABLE 287            NOVARAD: PRODUCTS/SOLUTIONS/SERVICES OFFERED             309

TABLE 288            ANALYZEDIRECT, INC.: COMPANY OVERVIEW                 311

TABLE 289            ANALYZEDIRECT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    311

TABLE 290            SYNTERMED INC.: COMPANY OVERVIEW                 312

TABLE 291            SYNTERMED INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    312

TABLE 292            PIE MEDICAL IMAGING B.V.: COMPANY OVERVIEW          313

TABLE 293            PIE MEDICAL IMAGING B.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    313

TABLE 294            PIE MEDICAL IMAGING B.V.: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021–DECEMBER 2024                 314

TABLE 295            PIE MEDICAL IMAGING B.V.: DEALS, JANUARY 2021– SEPTEMBER 2024  314

TABLE 296            INFINITT HEALTHCARE CO., LTD.: COMPANY OVERVIEW          315

TABLE 297            INFINITT HEALTHCARE CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    315

TABLE 298            INFINITT HEALTHCARE CO., LTD.: DEALS, JANUARY 2021– SEPTEMBER 2024               316

TABLE 299            BIOTRONICS 3D: COMPANY OVERVIEW                 317

TABLE 300            MINNOVAA INNOVATIONS OÜ: COMPANY OVERVIEW          318

TABLE 301            POSTDICOM: COMPANY OVERVIEW       319

TABLE 302            CITIUSTECH INC.: COMPANY OVERVIEW                 320

TABLE 303            CEEVRA, INC.: COMPANY OVERVIEW      321

LIST OF FIGURES

FIGURE 1              ADVANCED VISUALIZATION MARKET SEGMENTATION AND REGIONAL SCOPE              32

FIGURE 2              ADVANCED VISUALIZATION MARKET: RESEARCH DESIGN         37

FIGURE 3              PRIMARY SOURCES         40

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                41

FIGURE 5              MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS            42

FIGURE 6              BOTTOM-UP APPROACH: END-USER SPENDING ON ADVANCED VISUALIZATION               43

FIGURE 7              ADVANCED VISUALIZATION MARKET: CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024–2029        45

FIGURE 8              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 45

FIGURE 9              ADVANCED VISUALIZATION MARKET: TOP-DOWN APPROACH          46

FIGURE 10            DATA TRIANGULATION METHODOLOGY                 47

FIGURE 11            ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE,

2024 VS. 2029 (USD MILLION)      50

FIGURE 12            ADVANCED VISUALIZATION MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)               51

FIGURE 13            ADVANCED VISUALIZATION MARKET, BY APPLICATION,

2024 VS. 2029 (USD MILLION)      52

FIGURE 14            ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY,

2024 VS. 2029 (USD MILLION)      53

FIGURE 15            ADVANCED VISUALIZATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)         54

FIGURE 16            ADVANCED VISUALIZATION MARKET, BY REGION, 2024–2029           55

FIGURE 17            GROWING DEMAND FOR IMAGING TECHNOLOGIES TO DRIVE MARKET      56

FIGURE 18            SOFTWARE SEGMENT AND JAPAN TO LEAD ASIA PACIFIC MARKET IN 2024   57

FIGURE 19            CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       58

FIGURE 20            NORTH AMERICA TO DOMINATE ADVANCED VISUALIZATION MARKET DURING FORECAST PERIOD  58

FIGURE 21            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD  59

FIGURE 22            ADVANCED VISUALIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          60

FIGURE 23            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           70

FIGURE 24            ADVANCED VISUALIZATION MARKET: VALUE CHAIN ANALYSIS              74

FIGURE 25            ADVANCED VISUALIZATION MARKET ECOSYSTEM       75

FIGURE 26            INVESTMENT AND FUNDING SCENARIO, 2021–2024        77

FIGURE 27            ADVANCED VISUALIZATION MARKET: PATENT ANALYSIS,

JANUARY 2011–JANUARY 2025     82

FIGURE 28            ADVANCED VISUALIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS           92

FIGURE 29            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS            94

FIGURE 30            KEY BUYING CRITERIA FOR END USERS                 95

FIGURE 31            NORTH AMERICA: ADVANCED VISUALIZATION MARKET SNAPSHOT       159

FIGURE 32            ASIA PACIFIC: ADVANCED VISUALIZATION MARKET SNAPSHOT       195

FIGURE 33            REVENUE ANALYSIS OF KEY PLAYERS IN ADVANCED

VISUALIZATION MARKET 2019–2023         238

FIGURE 34            ADVANCED VISUALIZATION MARKET: MARKET SHARE ANALYSIS, 2023   239

FIGURE 35            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF ADVANCED VISUALIZATION VENDORS, 2024 240

FIGURE 36            EV/EBITDA OF KEY VENDORS, 2024         241

FIGURE 37            ADVANCED VISUALIZATION MARKET: BRAND/PRODUCT COMPARISON             242

FIGURE 38            ADVANCED VISUALIZATION MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023       244

FIGURE 39            ADVANCED VISUALIZATION MARKET: COMPANY FOOTPRINT 245

FIGURE 40            ADVANCED VISUALIZATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                 253

FIGURE 41            AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2023)    262

FIGURE 42            CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2023)      267

FIGURE 43            FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)      271

FIGURE 44            GE HEALTHCARE: COMPANY SNAPSHOT (2023)                 275

FIGURE 45            SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)             279

FIGURE 46            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)             282

FIGURE 47            STRYKER: COMPANY SNAPSHOT (2023) 287

FIGURE 48            CHANGE HEALTHCARE (UNITEDHEALTH GROUP): COMPANY SNAPSHOT (2023)   290

FIGURE 49            PRO MEDICUS, LTD.: COMPANY SNAPSHOT (2023)    297

FIGURE 50            4DMEDICAL: COMPANY SNAPSHOT (2023)                 304

FIGURE 51            SYNOPSYS, INC.: COMPANY SNAPSHOT (2023)                 307

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧